| Sun, Dec 6, 2009 | | • | Carfilzomib Safety Data From Ongoing Phase 2b Pivotal Trial in Relapsed and Refractory Multiple Myeloma Show Promising Safety and Tolerability
PR Newswire (Sun 10:30am)
| | Fri, Dec 4, 2009 | | • | Cramer's 'Mad Money' Recap: How to Play the Surprising Jobs Report (Update 1)
at TheStreet.com (Fri, Dec 4)
| | • | The Coming Week's Game Plan: Blood, Tech and Jeers
at CNBC (Fri, Dec 4)
| | • | Onyx Pharmaceuticals to Host American Society of Hematology (ASH) Investor Teleconference
PR Newswire (Fri, Dec 4)
| | Thu, Dec 3, 2009 | | • | Coverage initiated on Onyx Pharma by Soleil
Briefing.com (Thu, Dec 3)
| | Wed, Dec 2, 2009 | | • | S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders
PR Newswire (Wed, Dec 2)
| | Wed, Nov 25, 2009 | | • | Onyx Pharmaceuticals Announces December 2009 Investor Events
PR Newswire (Wed, Nov 25)
| | Fri, Nov 20, 2009 | | • | [$$] U.K. Watchdog Says Bayer's Nexavar Is Too Expensive
at The Wall Street Journal Online (Fri, Nov 20)
| | Thu, Nov 19, 2009 | | • | [$$] Corporate Watch
at The Wall Street Journal Online (Thu, Nov 19)
| | • | UK health unit rejects Bayer drug as too expensive
at MarketWatch (Thu, Nov 19)
| | Mon, Nov 16, 2009 | | • | Onyx wraps up $276M Proteolix buy
at bizjournals.com (Mon, Nov 16)
| | • | ONYX PHARMACEUTICALS INC Files SEC form 8-K, Completion of Acquisition or Disposition of Assets, Financial Statements
EDGAR Online (Mon, Nov 16)
| | • | Onyx Pharmaceuticals Completes Acquisition of Proteolix, Inc.
PR Newswire (Mon, Nov 16)
| | Thu, Nov 12, 2009 | | • | Trading Outlook for ZymoGenetics Inc. Issued by StockPreacher.com
GlobeNewswire (Thu, Nov 12)
| | Wed, Nov 11, 2009 | | • | Onyx Pharmaceuticals to Present at the Lazard Capital Markets 6th Annual Healthcare Conference
PR Newswire (Wed, Nov 11)
| | • | Healthcare Guru Adds Selected Biotech, Pharma Stakes
Indie Research (Wed, Nov 11)
| | Tue, Nov 10, 2009 | | • | Onyx Pharmaceuticals Announces Data Presentations Highlighting Carfilzomib and ONX 0803 at 51st American Society of Hematology Annual Meeting
PR Newswire (Tue, Nov 10)
| | • | Blood Cancer Meeting Abstracts Released: BioBuzz
at TheStreet.com (Tue, Nov 10)
| | • | Bristol Licenses Arthritis Drug: BioBuzz
at TheStreet.com (Tue, Nov 10)
| | • | Celgene in ASH Abstract Spotlight: BioBuzz
at TheStreet.com (Tue, Nov 10)
|
Add ONXX News to My Yahoo!:
 
| |
|
0.22% Nasdaq 0.00%
0.02 (0.07%) 
Headlines
